UFT and its metabolites inhibit the angiogenesis induced by murine renal cell carcinoma, as determined by a dorsal air sac assay in mice

Clinical Cancer Research

Volumn 5, Issue 8, 1999, Pages 2185-2191

  Yonekura, Kazuhiko ^a   Basaki, Yuji ^a   Chikahisa, Lumi ^a   Okabe, Soko ^a   Hashimoto, Akihiro ^a   Miyadera, Kazutaka ^a   Wierzba, Konstanty ^a   Yamada, Yuji ^a  

^a TAIHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

UFT;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG METABOLISM; GROWTH INHIBITION; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; PRIORITY JOURNAL;

4-BUTYROLACTONE; ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, RENAL CELL; CELL DIVISION; DIFFUSION CHAMBERS, CULTURE; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOXURIDINE; FLUOROURACIL; HYDROXYBUTYRATES; KIDNEY NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; TEGAFUR; TUMOR CELLS, CULTURED; URACIL;

EID: 0032795611     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Shibata, J., Murakami, K., Abe, M., Hashimoto, A., Utsugi, T., Fukushima, M., and Yamada, Y. Life prolonging effect of antitumor agents on postoperative adjuvant therapy in the lung spontaneous metastasis model in mice. Anticancer Res., 18: 1203-1210, 1998.
2. Einhorn, L. H., Loeher, P. J., Williams, S. D., Meyers, S., Gabrys, T., Nttan, S. R., Woodburn, R., Drasga, R., Songer, J., Fisher, W., Stephans, D., and Hui, S. Random prospective study of vindesine versus vindesine plus high-dose cisplatin versus vindesine plus cisplatin plus mitomycin C in advanced non-small-lung cancer. J. Clin. Oncol., 4: 1037-1043, 1986.
3. Gandara, D. R., Crowly, J., Livingston, R. B., Perez, E. A., Taylor, C. W., Weiss, G., Neefe, J. R., Hutcins, L. F., Roach, R. W., Grunberg, S. M., Braun, T. J., Natale, R. B., and Balcerzak, S. P. Evaluation of cisplatin intensity in metastatic non-small-cell lung cancer: a Phase III study of the Southwest Oncology group. J. Clin. Oncol., 11: 873-878, 1993.
4. Francis, P. A., Rigas, J. R., Kris, M. G., Pisters K. M. W., Orazem, J. P., Woolley, K. J., and Heelan, R. T. Phase II trial of docetaxel in patients with stage III and IV non-small cell lung cancer. J. Clin. Oncol., 12: 1232-1237, 1994.
5. Ausprunk, D. H., and Folkman, J. Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. Microvasc. Res., 14: 53-65, 1977.
6. Weinstat-Saslow, D., and Steeg, P. S. Angiogenesis and colonization in the tumor metastatic process: basic and applied advances. FASEB. J., 8: 401-407, 1994.
7. Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other diseases. Nature (Lond.) Med., 1: 27-31, 1995.
8. Oikawa, T., Sasaki, M., Inose, M., Shimamura, M., Kuboki, H., Hirano, S., Kumagai, H., Ishizuka, M., and Takeuchi, T. Effect of Cytogenin, a novel microbial product, on embryonic and tumor cell-induced angiogenic responses in vivo. Anticancer Res., 17: 1881-1886, 1997.
9. Sidky, Y. A., and Borden, E. C. Inhibition of angiogenesis by interferons: effects on tumor- and lymphocyte-induced vascular responses. Cancer Res., 47: 5155-5161, 1987.
10. Downs, E. C., Robertson, N. E., Riss, T. L., and Plunkett, M. L. Calcium alginate beads as a slow-release system for delivering angio-genic molecules in vivo and in vitro. J. Cell. Physiol., 152: 422-429, 1992.
11. Majewski, S., Szmurlo, A., Marczak, M., Jablonska, S., and Bollag, W. Synergistic effect of retinoids and interferon α on tumor-induced angiogenesis: anti-angiogenic effect on HPV-harboring tumor cell lines. Int. J. Cancer, 57: 81-85, 1994.
12. Fujita, F., Fujita, M., Shomozuma, K., Hirai, T., and Taguchi, T. Analyses of factors influencing the chemosensitivity of human tumors xenografted into nude mice. Jpn. J. Cancer Chemother., 13: 3221-3228, 1986.
13. Nio, Y., Kimura, H., Tsubono, M., Tseng, C-C., Kawabata, K., Masai, Y., Hayashi, H., Araya, S., Meyer, C., and Fukumoto, M. A comparative study of the antitumor activities of 5′-deoxy-5-fluorouridine and its prodrug trimethoxy bezoyl-5′-deoxy-5-fluorouridine (Ro09-1390) on human digestive organ cancer xenograft lines transplanted into nude mice. Anti-Cancer Drugs, 3: 387-393, 1992.
14. Inaba, M., Kobayashi, T., Tashiro, T., and Sakurai, Y. Pharmacokinetic approach to rational therapeutic doses for human tumor-bearing nude mice. Cancer (Phila.), 79: 509-516, 1988.
15. Mosmmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65: 55-63, 1983.
16. Fujii, S., Kitano, S., Ikenaka, K., and Shirasaka, T. Studies on coadministration of uracil or cytosine on antitumor activity of FT-207 or 5-FU derivatives. Jpn. J. Cancer Chemother., 6: 377-384, 1979.
17. Wu, A. T., Au, J. L., and Sadee, W. Hydroxylated metabolites of R,S-1-(tetrahydro-2-furanyl)-5-fluorouracil (Ftorafur) in rats and rabbits. Cancer Res., 38: 210-214, 1978.
18. Au, J. L., and Sadee, W. Activation of Ftorafur [R,S-1-(tetrahydro-2-furanyl)-5-fluorouracil] to 5-fluorouracil and γ-butyrolactone. Cancer Res., 40: 2814-2819, 1980.
19. Marunaka, T., Minami, Y., Umeno, Y., Yasuda, A., Sato, T., and Fujii, S. Identification of metabolites of 1-(tetrahydro-2-furanyl)-5-fluorouracil (FT-207) formed in vitro by rat liver. Chem. Pharm. Bull., 28: 1795-1803, 1980.
20. Kurebayashi, J., Nukatsuka, M., Fujioka, A., Saito, H., Takeda, S., Unemi, N., Fukumori, H., Kurosumi, M., Sonoo, H., and Dickson, R. B. Postsurgical oral administration of uracil and tegafur inhibits progression on micrometastasis of human breast cancer cell in nude mice. Clin. Cancer Res., 3: 653-659, 1997.
21. Nauyen, M., Shing, Y., and Folkman, J. Quantification of angiogenesis and anti-angiogenesis in the chick embryo chorioallantoic membrane. Microvasc. Res., 47: 31-40, 1994.
22. Thompson, J. A., Anderson, K. D., DiPietro, J. M., Zwiebel, J. A., Zametta, M., Anderson, W. F., and Maciag, T. Site-directed neovessel formation in vivo. Science (Washington DC), 241: 1349-1352, 1988.
23. Jain, R. K., Schlenger, K., and Yuan, F. Quantification angiogenesis assays: progress and problems. Nature (Lond.), 3: 1203-1208, 1997.
24. Fujita, H., and Ogawa, K. The tissue distribution and activation of 1-hexylcarbamoyl-5-fluorouracil (HCFU). Rinsyo Yakuri, 12: 233-243, 1981.
25. Kimura, K., and Suga, S. 5-FU and its derivatives. Jpn. J. Cancer Chemother., 9: 1321-1326, 1982.
26. Ferrara, S. D., Zotti, S., Tedeschi, L., Frison, G., Castagna, F., Gallimbert, L., Gessa, G. L., and Palatini, P. Pharmacokinetics of γ-hydroxybutyric acid in alcohol-dependent patients after single and repeated oral doses. Br. J. Clin. Pharmacol., 34: 231-235, 1992.
27. Addolorato, G., Cibin, M., Caprista, E., Beghe, F., Gessa, G., Stefanni, G. F., and Gasbarrini, G. Maintaining abstinence from alcohol with γ-hydroxybutylic acid. Lancet, 351: 38, 1998.
28. Vasil'eva, L. S., Kuz'menko, V. V., and Malyshev, V. V. Modification of the time course of aseptic inflammation by sodium hydroxybutyrate. Biull. Eksp. Biol. Med., 112: 1553-1555, 1991.
29. Fujita, H., Ogawa, K., Nakagawa, H., Kawaguchi, K., Nakagawa, Y., and Doi, Y. Pharmacokinetics of 5́-deoxy-5-fluorouridine (5′-DFUR). J. Jpn. Soc. Cancer Ther., 18: 916-926, 1983.
30. Yamada, Y., Kawamura, T., Gotohda, E., Akiyama, J., Hosokawa, M., Kodama, T., and Kobayashi, H. Effect of normal allogeneic lymphoid cell transfer in combination with chemotherapy on a transplantable tumor in rats. Cancer Res., 40: 954-958, 1980.
31. Yamada, Y., Miyauchi, S., and Unemi, N. Differential effects of 5-fluorouracil analogs on humoral and cell-mediated responses in mice: augmentation of delayed hypersensitivity response against picryl chloride by 1,3-bis(tetrahydro-2-furanyl)-5-fluoro-2,4-pyrimidinedione (FD-1), a new anti-tumor drug. J. Clin. Lab. Immunol., 4: 153-157, 1980.
32. Griffioen, A. W., Damen, C. A., Blijham, G. H., and Groenewegen, G. Tumor angiogenesis is accompanied by a decreased inflammatory response of tumor-associated endothelium. Blood, 88: 667-673, 1996.
33. Watanabe, M., McCormick, K. L., Volker, K., Ortaldo, J. R., Wigginton, J. M., Brunda, M. J., Wiltrout, R. H., and Fogler, W. E. Regulation of local host-mediated anti-tumor mechanisms by cytokines: direct and indirect effects on leukocyte recruitment and angiogenesis. Am. J. Pathol., 150: 1869-1880, 1997.
34. Gupta, S. K., Lysko, P. G., Pillarisetti, K., Ohlstein, E., and Stadel, J. M. Chemokine receptors in human endothelial cells. Functional expression of CXCR4 and its transcriptional regulation by inflammatory cytokines. J. Biol. Chem., 273: 4282-4287, 1998.